口腔癌,血管内皮生长因子,树突状细胞,调节性T细胞 ," /> 口腔癌,血管内皮生长因子,树突状细胞,调节性T细胞 ,"/> Oral cancer,Vascular endothelial growth factor(VEGF),Dendritic cell(DC),Regulatory T lymphocyte(Treg) ,"/> <p class="MsoNormal" style="text-align:justify;"> 口腔癌组织中VEGF与DC成熟及Treg关系的临床观察

临床肿瘤学杂志 ›› 2018, Vol. 23 ›› Issue (9): 817-822.

• 论著 • 上一篇    下一篇

口腔癌组织中VEGF与DC成熟及Treg关系的临床观察

  

  1. 1  810000  西宁  西宁市口腔医院牙周病科

    2  100142  西宁市第三人民医院口腔科

    3  100142  西宁市第三人民医院病理科

  • 收稿日期:2018-05-19 修回日期:2018-06-19 出版日期:2018-09-30 发布日期:2018-11-28

Clinical observation of vascular endothelial growth factor and DC maturation and Treg in oral cancer

  1. Department of Periodontitis, Xining Oral Hospital, Xining 810000, China
  • Received:2018-05-19 Revised:2018-06-19 Online:2018-09-30 Published:2018-11-28

摘要: 目的 探讨口腔癌组织中血管内皮生长因子(VEGF)、树突状细胞(DC)分化成熟和调节性T细胞(Treg)表达,并分析影响口腔癌复发的因素。方法 收集2015年1月至2015年6月间的67例患者的临床病例资料,随访患者复发情况。采用免疫组化SP法检测口腔癌组织中VEGF、CD83、CD1α+、Foxp3的表达情况,分析其表达与口腔癌术后复发的关系,采用Cox回归模型分析影响口腔癌复发的独立因素。结果 口腔癌组织中VEGF阳性表达率为59.7%(40/67),与肿瘤发生部位、TNM分期和肿瘤体积有关(P<0.05)。CD83和Foxp3阳性表达率分别为52.2%(35/67)和38.8%(28/67),与TNM分期和淋巴结转移有关(P<0.05)。CD1α阳性表达率为41.8%(26/67),与TNM分期有关(P<0.05)。术后平均随访(31.45±6.23)个月,其中21例(31.34%)患者复发,复发患者和未复发患者TNM分期、淋巴结转移、VEGF表达情况、CD83+、CD1α+树突状细胞分布情况以及Foxp3+T细胞分布情况之间差异存在统计学意义(P<0.05)。经Spearman秩相关分析,VEGF表达与CD83+树突状细胞分布呈负相关,而与Foxp3+T细胞分布呈正相关(P<0.05);CD83+和CD1α+树突状细胞分布呈负相关(P<0.05);Foxp3+T细胞分布与CD1α+树突状细胞分布呈正相关(P<0.05)。多因素Cox回归模型分析显示,TNM分期晚、淋巴结转移、VEGF阳性表达、CD1α+低分布、Foxp3+高分布是术后复发的独立危险因素(P<0.05)。结论 肿瘤微环境中VEGF与成熟DCs数量减少有关,而不成熟DCs与Treg细胞的分布呈正相关,可作为判断口腔癌患者预后的参考指标。

关键词:

口腔癌')">"> 口腔癌, 血管内皮生长因子, 树突状细胞, 调节性T细胞

Abstract:

Objective To investigate the expression of vascular endothelial growth factor (VEGF), dendritic cell (DC) differentiation and regulatory T cells (Treg) in oral cancer, and to analyze the factors that affect the recurrence of oral cancer. Methods  The clinical data of 67 patients from January 2015 to June 2015 were collected. The recurrence of the patients was followed up. The expression of VEGF, CD83, CD1αand Foxp3 in oral cancer tissues was detected by immunohistochemical SP, and the relationship between the expression and recurrence of oral cancer was analyzed. The independent factors affecting the recurrence of oral cancer were analyzed by Cox regression model. Results The positive expression rate of VEGF in oral cancer tissues was 59.7% (40/67), which was related to tumor location, TNM stage and tumor volume (P<0.05). The positive expression rates of CD83 and Foxp3 were 52.2% (35/67) and 38.8% (28/67), respectively, which were related to TNM staging and lymph node metastasis (P<0.05). The positive expression rate of CD1 alpha was 41.8% (26/67), which was related to TNM stage (P<0.05). The mean follow-up period was (31.45±6.23) months, and 21 patients relapsed. There were significant differences in TNM staging, lymph node metastasis, VEGF expression, CD1α, CD1 alpha+ dendritic cell distribution and the distribution of Foxp3+T cells in recurrent and non recurrent patients (P<0.05). The Spearman rank correlation analysis showed that VEGF expression was negatively correlated with the distribution of CD83+ dendritic cells, but positively correlated with the distribution of Foxp3+T cells (P<0.05), and the distribution of CD83+and CD1α+ dendritic cells was negatively correlated (P<0.05), and the distribution of Foxp3+T cells was positively correlated with the distribution of CD1α+ dendritic cells (P<0.05). The analysis of multiple factor Cox regression model showed that TNM staging, lymph node metastasis, VEGF positive expression, CD1α+ low distribution and high Foxp3+distribution were independent risk factors for postoperative recurrence (P<0.05). Conclusion VEGF in the tumor microenvironment is related to the decrease in the number of mature DCs, but the distribution of immature DCs is positively correlated with the distribution of Treg cells, which can be used as a reference index to judge the prognosis of oral cancer patients.

Key words:

Oral cancer')">"> Oral cancer, Vascular endothelial growth factor(VEGF), Dendritic cell(DC), Regulatory T lymphocyte(Treg)

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 刘锦;李贵新;马传香. 恶性黑色素瘤腹腔转移1例[J]. 临床肿瘤学杂志, 2009, 14(1): 96 .
[2] 石 玮1,华海清2,王兴华1. 放疗对肠屏障功能的影响及研究进展[J]. 临床肿瘤学杂志, 2009, 14(1): 89 .
[3] 王杰军,李 睿. NCCN成人癌痛临床实践指南解读[J]. 临床肿瘤学杂志, 2009, 14(1): 80 .
[4] 崔传亮,迟志宏,袁香庆,斯 璐,盛锡楠,郭 军. 重组人血管内皮抑制素联合化疗一线治疗晚期黑色素瘤的Ⅱ期临床研究[J]. 临床肿瘤学杂志, 2009, 14(1): 74 .
[5]

高亚杰1,关小倩1,杨海林1,张 阳2,欧阳学农3,杨建伟4,陈 焰5,徐建明6,赵宣良7,王宝成8,刘文超9,张贺龙10,南克俊11,王湘辉12

. 注射用左亚叶酸钙联合治疗晚期胃癌和结直肠癌的Ⅱ期临床研究[J]. 临床肿瘤学杂志, 2009, 14(1): 47 .
[6]  白秀丽1,马振刚1,李际君2. 紫杉醇联合卡培他滨治疗进展期胃癌的临床观察[J]. 临床肿瘤学杂志, 2009, 14(1): 68 .
[7] 徐卫国1,杨小青2,郝世柱1,宋纪宁1,张鹏东1,胡潺潺1,王文雅1. 大肠癌组织中Neuropilin-1的表达及其与肿瘤血管生成的相关性研究[J]. 临床肿瘤学杂志, 2009, 14(1): 29 .
[8] 许景艳1,欧阳建,章宜芬2,周荣富1,陈 兵1,张启国1,杨永公1,邵小雁1,徐 勇1,关朝阳1. 原发性肋骨血管肉瘤的诊治探讨[J]. 临床肿瘤学杂志, 2009, 14(1): 70 .
[9] 徐晓明1,唐金海1,刘万花2,郑凯尔2,秦建伟1,赵祥生1,张 彤3. 触诊阴性乳腺癌的定位方法与同期手术治疗[J]. 临床肿瘤学杂志, 2009, 14(1): 43 .
[10] 张艳玲,邹 岚,肖 红,黄海辉,谭崇富,阮志华,王 希,梁后杰,庞学利. 影像引导调强放射治疗鼻咽癌[J]. 临床肿瘤学杂志, 2009, 14(1): 51 .